J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea
· Delayed Price · Currency is KRW 7,350.00
-400.00 (-5.16%)
At close: Mar 9, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 42.98 billion as of March 9, 2026. Its market cap has decreased by -12.43% in one year.
Market Cap
42.98B
Enterprise Value
32.76B
Revenue
31.12B
Ranking
n/a
PE Ratio
18.97
Stock Price
7,350.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 42.98B, a decrease of -70.34%. That is a compound annual growth rate of -46.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 42.98B | -14.53% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NGeneBio | 53.15B |
| SCM Lifescience | 38.01B |
| EyeGene | 56.54B |
| Aptamer Sciences | 56.56B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.33B |
| SunBio,Inc. | 64.75B |